BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 22913682)

  • 1. Adult-onset immunodeficiency in Thailand and Taiwan.
    Browne SK; Burbelo PD; Chetchotisakd P; Suputtamongkol Y; Kiertiburanakul S; Shaw PA; Kirk JL; Jutivorakool K; Zaman R; Ding L; Hsu AP; Patel SY; Olivier KN; Lulitanond V; Mootsikapun P; Anunnatsiri S; Angkasekwinai N; Sathapatayavongs B; Hsueh PR; Shieh CC; Brown MR; Thongnoppakhun W; Claypool R; Sampaio EP; Thepthai C; Waywa D; Dacombe C; Reizes Y; Zelazny AM; Saleeb P; Rosen LB; Mo A; Iadarola M; Holland SM
    N Engl J Med; 2012 Aug; 367(8):725-34. PubMed ID: 22913682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in Northern Thailand.
    Wongkulab P; Wipasa J; Chaiwarith R; Supparatpinyo K
    PLoS One; 2013; 8(9):e76371. PubMed ID: 24086734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
    Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
    Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.
    Angkasekwinai N; Suputtamongkol Y; Phoompoung P; Pithukpakorn M; Wongswat E; Umrod P; Tongsai S; Foongladda S
    PLoS One; 2019; 14(4):e0215581. PubMed ID: 31022229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.
    Patel SY; Ding L; Brown MR; Lantz L; Gay T; Cohen S; Martyak LA; Kubak B; Holland SM
    J Immunol; 2005 Oct; 175(7):4769-76. PubMed ID: 16177125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interferon-γ autoantibody and opportunistic infections: case series and review of the literature.
    Kampitak T; Suwanpimolkul G; Browne S; Suankratay C
    Infection; 2011 Feb; 39(1):65-71. PubMed ID: 21128092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
    Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
    Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
    Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
    BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.
    Hong GH; Ortega-Villa AM; Hunsberger S; Chetchotisakd P; Anunnatsiri S; Mootsikapun P; Rosen LB; Zerbe CS; Holland SM
    Clin Infect Dis; 2020 Jun; 71(1):53-62. PubMed ID: 31429907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    Cheng A; Kashyap A; Salvator H; Rosen LB; Colby D; Ardeshir-Larijani F; Loehrer PJ; Ding L; Lugo Reyes SO; Riminton S; Ballman M; Rocco JM; Marciano BE; Freeman AF; Browne SK; Hsu AP; Zelazny A; Rajan A; Sereti I; Zerbe CS; Lionakis MS; Holland SM
    N Engl J Med; 2024 Mar; 390(12):1105-1117. PubMed ID: 38507753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options.
    Barcenas-Morales G; Cortes-Acevedo P; Doffinger R
    Curr Opin Infect Dis; 2019 Aug; 32(4):330-336. PubMed ID: 31116133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections.
    Guo J; Ning XQ; Ding JY; Zheng YQ; Shi NN; Wu FY; Lin YK; Shih HP; Ting HT; Liang G; Lu XC; Kong JL; Wang K; Lu YB; Fu YJ; Hu R; Li TM; Pan KS; Li XY; Huang CY; Lo YF; Chang IY; Yeh CF; Tu KH; Tsai YH; Ku CL; Cao CW
    J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32880631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Manifestations in Patients with Adult-onset Immunodeficiency due to Anti-interferon-gamma Autoantibody: A Relationship with Systemic Infections.
    Jutivorakool K; Sittiwattanawong P; Kantikosum K; Hurst CP; Kumtornrut C; Asawanonda P; Klaewsongkram J; Rerknimitr P
    Acta Derm Venereol; 2018 Aug; 98(8):742-747. PubMed ID: 29701234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated
    Chaononghin S; Visuttichaikit S; Apisarnthanarak A; Khawcharoenporn T
    Int J Mycobacteriol; 2020; 9(1):91-94. PubMed ID: 32474495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-Onset Disseminated Mycobacterium avium intracellulare Complex Infection (MAC), Cerebral Toxoplasmosis and Salmonella Sepsis in a German Caucasian Patient with Unusual Anti-Interferon-Gamma IgG1 Autoantibodies.
    Hanitsch LG; Löbel M; Müller-Redetzky H; Schürmann M; Suttorp N; Unterwalder N; Mönnich U; Meisel C; Wittke K; Volk HD; Scheibenbogen C; Kölsch U
    J Clin Immunol; 2015 May; 35(4):361-5. PubMed ID: 25875701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.